Verkkogrifols is accelerating adoption of xembifyยฎ as part of its broader immunoglobulin business strategy focused on treating immunodeficiency disorders,.

$7. 5m allocated to.

Verkkorare diseases remain a formidable public health challenge.

Recommended for you
You may also like